EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Therapeutic Choices in Patients with Ph-Positive Chronic Myelogenous Leukemia In Mexico in the Era of Tyrosine Kinase Inhibitors: Stem Cell Transplantation or Tyrosine Kinase Inhibitors? Fifteen Years Later

Max Robles-Nasta, Daniela Sánchez-Bonilla, Moisés M. Gallardo-Pérez, Edgar J. Hernández-Flores, Merittzel A. Montes-Robles, María de L. Pastelín-Martínez, Juan C. Olivares-Gazca, Guillermo J. Ruiz-Delgado, Guillermo J. Ruiz-Argüelles

Revista de Investigación Clínica · 2024

DOI: 10.24875/ric.23000274 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Revista de Investigación Clínica, 2024. Verfasst von Max Robles-Nasta und 8 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Hematología y Medicina Interna, Clínica Ruiz, Puebla; Faculty of Medicine, Universidad Popular Autónoma del Estado de Puebla, Puebla. Hauptthemen laut MEDLINE: Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Protein Kinase Inhibitors, Hematopoietic Stem Cell Transplantation. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myelogenous, Chronic, BCR-ABL PositiveProtein Kinase InhibitorsHematopoietic Stem Cell TransplantationHumansMexicoRetrospective StudiesMaleFemaleMiddle AgedAdultYoung AdultAgedAdolescentSurvival RateTransplantation, HomologousTyrosine Kinase Inhibitors

Stichwörter der Autor:innen

Allogeneic hematopoietic stem cell transplantationChronic myelogenous leukemiaGraft-versus-host diseaseLow/middle-income countriesTyrosine kinase inhibitor

Substanzen

Protein Kinase InhibitorsTyrosine Kinase Inhibitors

Autor:innen und Institutionen

  • Centro de Hematología y Medicina Interna, Clínica Ruiz, Puebla; Faculty of Medicine, Universidad Popular Autónoma del Estado de Puebla, Puebla.
  • Centro de Hematología y Medicina Interna, Clínica Ruiz, Puebla.
  • Centro de Hematología y Medicina Interna, Clínica Ruiz, Puebla; Faculty of Medicine, Universidad Anáhuac Puebla, Puebla, Mexico.

Zitieren

APA

Robles-Nasta, M., Sánchez-Bonilla, D., Gallardo-Pérez, M. M., Hernández-Flores, E. J., Montes-Robles, M. A., Pastelín-Martínez, M. L., Olivares-Gazca, J. C., Ruiz-Delgado, G. J., & Ruiz-Argüelles, G. J. (2024). Therapeutic Choices in Patients with Ph-Positive Chronic Myelogenous Leukemia In Mexico in the Era of Tyrosine Kinase Inhibitors: Stem Cell Transplantation or Tyrosine Kinase Inhibitors? Fifteen Years Later. Revista de Investigación Clínica. https://doi.org/10.24875/ric.23000274

Vancouver

Robles-Nasta M, Sánchez-Bonilla D, Gallardo-Pérez MM, Hernández-Flores EJ, Montes-Robles MA, Pastelín-Martínez ML, et al. Therapeutic Choices in Patients with Ph-Positive Chronic Myelogenous Leukemia In Mexico in the Era of Tyrosine Kinase Inhibitors: Stem Cell Transplantation or Tyrosine Kinase Inhibitors? Fifteen Years Later. Revista de Investigación Clínica. 2024. doi:10.24875/ric.23000274

BibTeX
@article{RoblesNasta2024,
  author = {Robles-Nasta, Max and Sánchez-Bonilla, Daniela and Gallardo-Pérez, Moisés M. and Hernández-Flores, Edgar J. and Montes-Robles, Merittzel A. and Pastelín-Martínez, María de L. and Olivares-Gazca, Juan C. and Ruiz-Delgado, Guillermo J. and Ruiz-Argüelles, Guillermo J.},
  title = {Therapeutic Choices in Patients with Ph-Positive Chronic Myelogenous Leukemia In Mexico in the Era of Tyrosine Kinase Inhibitors: Stem Cell Transplantation or Tyrosine Kinase Inhibitors? Fifteen Years Later},
  journal = {Revista de Investigación Clínica},
  year = {2024},
  doi = {10.24875/ric.23000274}
}
Kostenlos starten →